Immunological response to two hepatitis B vaccines administered in two different schedules

K M Girisha1, J R Kamat, G Nataraj

  • 1Department of Pediatrics, Seth GS Medical College and KEM Hospital, Parel, Mumbai. girishkatta@gmail.com

Insights

The 0, 1, 6 month vaccination schedule induces a higher antibody response for hepatitis B than the 0, 1, 2 month schedule. Both schedules provide excellent protection with plasma-derived and recombinant vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Hepatitis B virus (HBV) infection is a significant global health concern.
  • Effective vaccination strategies are crucial for preventing HBV transmission.
  • Vaccines containing pre-S and S antigens may offer enhanced immunogenicity compared to S antigen-only vaccines.

Purpose of the Study:

  • To compare the immunogenicity of a plasma-derived hepatitis B vaccine (pre-S and S antigens) with a recombinant hepatitis B vaccine (S antigen only).
  • To evaluate two different vaccination schedules: 0, 1, 2 months versus 0, 1, 6 months.
  • To assess antibody response, seroconversion, and seroprotection rates in infants.

Main Methods:

  • A randomized trial involving 159 healthy infants.
  • Infants received either the plasma-derived or recombinant hepatitis B vaccine according to one of the two schedules.
  • Anti-HBs antibody titers were measured before vaccination and one month after the second and third doses.

Main Results:

  • Both vaccine types demonstrated high rates of seroconversion and seroprotection.
  • Antibody responses were comparable between the plasma-derived and recombinant vaccines.
  • The 0, 1, 6 month schedule resulted in significantly higher anti-HBs antibody levels compared to the 0, 1, 2 month schedule.

Conclusions:

  • The 0, 1, 6 month vaccination schedule is superior in inducing higher antibody levels for hepatitis B.
  • Both tested hepatitis B vaccines, regardless of antigen composition, achieve good seroconversion and seroprotection rates.
  • The choice of vaccination schedule significantly impacts the magnitude of the antibody response.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...